Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for Prevention of Erectile Dysfunction in Prostate Cancer Radiotherapy
NCT00931528Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Nov 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in erectile dysfunction (ED) comparing Tadalafil with Placebo (2 arms). Primary endpoint: Percentage of Patients Maintaining Spontaneous (Off-drug) Erectile Function. Started Nov 2009; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00931528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00931528.